Physician

Faoud Ishmael, M.D.

According to 2025 Medicare claims, Faoud Ishmael, M.D. (NPI: 1275670028) practices allergy/immunology in the State College, PA market, with the plurality of this provider's patient population coming from Centre, PA. This provider's primary affiliated billing organization is MOUNT NITTANY MEDICAL CENTER HEALTH SERVICES INC (NPI: 1598992554; TIN: 510426500) and primary practice location at 16803-5500.

Ishmael's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 148 traditional Medicare patients, billed 6,122 HCPCS/CPT codes, and received $197,460 in Medicare payments. The top billing code was 95076 (Test for allergy using ingested items, initial 2 hours). Part D data shows 1,386 prescription claims across 238 beneficiaries totaling $927,717 in drug costs, led by Dupixent Syringe (Dupilumab). DME data shows 135 claims. Open Payments data shows 6 records totaling $225. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $14,045 to $197,460. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $189,640 to $927,717. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $2,012 to $1,535.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	102	636	$14,045
2016	111	600	$13,514
2017	67	224	$6,428
2018	103	1,593	$33,521
2019	112	3,089	$71,131
2020	127	2,572	$112,366
2021	162	6,474	$265,526
2022	187	9,724	$352,653
2023	162	4,870	$172,434
2024	148	6,122	$197,460

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	67	407	$189,640
2016	96	640	$199,597
2017	54	388	$381,925
2018	76	343	$255,708
2019	114	529	$168,894
2020	145	775	$363,534
2021	187	1,051	$557,113
2022	224	1,179	$778,674
2023	225	1,355	$1,006,737
2024	238	1,386	$927,717

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	50	$69,147
2016	N/R	205	$304,197
2017	N/R	194	$264,546
2018	N/R	177	$205,401
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	31	$61,879
2022	N/R	74	$130,143
2023	N/R	143	$241,229
2024	N/R	135	$246,375

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95076	Test for allergy using ingested items, initial 2 hours	18	21	$92
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	62	75	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	39	45	$65
96372	Injection of drug or substance under skin or into muscle	24	148	$10
95117	Professional service for multiple injections of allergen	25	144	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Syringe	Dupilumab	67	2,044	$273,277
Tezspire	Tezepelumab-Ekko	25	700	$96,939
Dupixent Pen	Dupilumab	22	672	$95,551
Fasenra	Benralizumab	15	784	$88,771
Xolair	Omalizumab	16	504	$65,925

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	50	$212,855
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	13	$27,780
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	13	$4,285
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	11	$729
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	48	$726

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$225	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Faoud Ishmael, M.D.?

Tedicare shows public-source Medicare data for Faoud Ishmael, M.D. (NPI 1275670028), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Faoud Ishmael, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Faoud Ishmael, M.D.?

Faoud Ishmael, M.D. is linked to MOUNT NITTANY MEDICAL CENTER HEALTH SERVICES INC (billing NPI 1598992554) in the available physician profile data.

Does Faoud Ishmael, M.D. have Open Payments data?

Faoud Ishmael, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.